Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-25-000115
Filing Date
2025-07-09
Accepted
2025-07-09 06:01:25
Documents
28
Period of Report
2025-07-09

Document Format Files

Seq Description Document Type Size
1 6-K form6k_070925.htm 6-K 11533
2 EX-99.1 a2025-cg_report.htm EX-99.1 126804
3 GRAPHIC a2025-cg_report001.jpg GRAPHIC 240462
4 GRAPHIC a2025-cg_report002.jpg GRAPHIC 328478
5 GRAPHIC a2025-cg_report003.jpg GRAPHIC 301862
6 GRAPHIC a2025-cg_report004.jpg GRAPHIC 295122
7 GRAPHIC a2025-cg_report005.jpg GRAPHIC 359303
8 GRAPHIC a2025-cg_report006.jpg GRAPHIC 270149
9 GRAPHIC a2025-cg_report007.jpg GRAPHIC 227418
10 GRAPHIC a2025-cg_report008.jpg GRAPHIC 226399
11 GRAPHIC a2025-cg_report009.jpg GRAPHIC 223885
12 GRAPHIC a2025-cg_report010.jpg GRAPHIC 223328
13 GRAPHIC a2025-cg_report011.jpg GRAPHIC 226411
14 GRAPHIC a2025-cg_report012.jpg GRAPHIC 251510
15 GRAPHIC a2025-cg_report013.jpg GRAPHIC 269875
16 GRAPHIC a2025-cg_report014.jpg GRAPHIC 289929
17 GRAPHIC a2025-cg_report015.jpg GRAPHIC 277774
18 GRAPHIC a2025-cg_report016.jpg GRAPHIC 292515
19 GRAPHIC a2025-cg_report017.jpg GRAPHIC 278078
20 GRAPHIC a2025-cg_report018.jpg GRAPHIC 297336
21 GRAPHIC a2025-cg_report019.jpg GRAPHIC 319022
22 GRAPHIC a2025-cg_report020.jpg GRAPHIC 274750
23 GRAPHIC a2025-cg_report021.jpg GRAPHIC 104925
24 GRAPHIC a2025-cg_report022.jpg GRAPHIC 83313
25 GRAPHIC a2025-cg_report023.jpg GRAPHIC 181120
26 GRAPHIC a2025-cg_report024.jpg GRAPHIC 221704
27 GRAPHIC a2025-cg_report025.jpg GRAPHIC 170467
28 GRAPHIC a2025-cg_report026.jpg GRAPHIC 200088
  Complete submission text file 0001395064-25-000115.txt   9004893
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 251112203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)